What do think of Guv Brown Veto of Paying for human eggs? California Guv Jerry Brown has vetoed a bill that would have made it legal in California to pay women for egg donation for research. Take our poll below.
What do think of Guv Brown Veto of Paying for human eggs Read More »
I invite you, my blog readers, for the possible chance to guest blog here on ipscell.com with our audience above 10,000 a week of the who’s who of the stem cell world. What’s the topic? The positive! This invitation is to blog in 500 words or less about what you believe is the single best
Guest blogging invite: what is top stem cell company & why? Read More »
Would you eat a burger made from stem cells or what we call a test tube burger? Take our polls. If you answered either “Probably not” or “No way!”, why? Take our 2nd poll below. If you answered “Probably” or “Definitely Yes!” please take the 3rd poll.
Would you eat the stem cell test tube burger? Take our polls! Read More »
A new paper suggests a hopeful short-term safety profile of laboratory-grown stem cells for treatment of arthritis, but there are some important limitations to the study too. A debate continues to bubble over whether to classify laboratory-propagated stem cells as biological drugs. A persistent issue has been whether the growth of stem cells in culture
Short-term safety of lab-grown stem cells for arthritis: encouraging, but key caveats Read More »
How important is the new development of all chemical reprogramming to make iPS cells? The group led by Hongkui Deng at Peking University in Beijing reported in Science that they used 7 chemicals to make what appear to be mouse iPS cells. I’m hearing a wide range of opinions directly from people in the know. What’s
What do you think of all chemical reprogramming? Take our poll Read More »
What the heck is going on with Intellicell Biosystems, Inc. (SVFC, also SVFCE), a stem cell corporation run by Dr. Steven Victor? Why are some on Wall Street seeming so bullish on the company lately? What’s the real story and the facts? What is the key background on this company? Wall Street has been buying
Wall Street Weirdness Over Stem Cell Biotech Intellicell (SVFC) Read More »
In a rare sign of stem cell international regulatory unity, the Japanese Health Ministry (厚生労働省) and the US FDA have agreed to develop a joint, unified regulatory framework for clinical studies of human iPS cells for use in treating retinal diseases. Presumably the rules would also guide clinical use of iPS cells to treat other
FDA & Japanese Health Ministry (厚生労働省) To Develop iPS cell clinical rules Read More »
In 2012 there was some grumbling about that year’s Annual ISSCR Meeting in Japan. If fact in last year’s polling only about 33% of people collectively felt positively about the meeting and by the far the top answer for rating the 2012 ISSCR Annual Meeting was “So so” at 43%. What about this year’s 2013
Polling: ISSCR 2013 meeting clearly better than last year’s Read More »
This is a guest post on ISSCR 2013. By Dr. Susan Lim A record 4100 delegates attended the 11th Annual Meeting of the International Society for Stem Cell Research (ISSCR), held at the Convention and Exhibition Center in Boston from 12-15 June 2013. Co-sponsored by the Harvard Stem Cell Institute, the Meeting featured 7 Plenary
Delightful overview of ISSCR 2013 by guest blogger Dr. Susan Lim Read More »
If you attended ISSCR 2013, the big annual stem cell meeting held in Boston this year, did you like it overall? Take our polls below.
Polls on ISSCR 2013: did you like it and how’d it stack up compared to ISSCR 2012? Read More »